A new scientific review published by the American Medical Association (AMA) shows that use of psilocybin has “surged” in the ...
The Trump administration is set to weigh in on whether the hallucinogenic compound psilocybin should be moved into a less restrictive class of drugs under federal regulations. Regulation of psilocybin ...
Psilocybin, the active ingredient in magic mushrooms, could potentially be used to treat depression, according to new research published on Wednesday, the latest evidence suggesting psychedelics could ...
Opinion paper calls for clarity on the definition of "psychedelic-assisted therapy" using psilocybin
Leading psychiatrists and researchers examine common assumptions about the term “psychedelic-assisted psychotherapy” and the role of psychotherapy when evaluating psilocybin treatment. Authors ...
Penn researchers found that psilocybin can calm brain circuits tied to pain and mood, easing both physical suffering and emotional distress in animal studies. The compound works in the anterior ...
There is an urgent need for improved treatments for postpartum depression in humans. Dosing mice with psilocybin did not alleviate stress responses and depressive behavior in mice that had recently ...
Doctors often prescribe a type of antidepressant known as selective serotonin reuptake inhibitors for treating depressive symptoms. But while SSRI antidepressants can help in offering relief from ...
Opinion paper calls for clarity on the definition of “psychedelic-assisted therapy” using psilocybin
Leading psychiatrists and researchers examine common assumptions about the term “psychedelic-assisted psychotherapy” and the role of psychotherapy when evaluating psilocybin treatment. Authors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback